Philipp Linde
Papers
1
Total Citations
2
H-Index
1
About
Philipp Linde is a clinical researcher specializing in the intersection of radiation oncology and metastatic disease management, with a particular focus on stereotactic body radiotherapy (SBRT) for oligometastatic patients. His work centers on optimizing robotic SBRT (rSBRT) delivery to lung metastases, addressing critical questions about treatment efficacy and toxicity in this emerging therapeutic paradigm. In his most cited study, "Efficacy and Toxicity of Robotic Stereotactic Body Radiotherapy of Lung Metastases in Patients With Oligometastatic Disease" (2023), Linde investigates the factors determining successful rSBRT outcomes, contributing valuable data to a field where evidence remains scarce. Though early in his citation impact with 2 citations on this key paper, his research addresses a pressing clinical need—identifying which patients with limited metastatic spread benefit most from precise, high-dose radiation while minimizing harm. Linde’s work helps bridge the gap between technological capability and patient selection, offering practical insights for oncologists navigating the complexities of oligometastatic treatment. As robotic radiotherapy continues to evolve, his contributions provide a foundation for more personalized, evidence-based approaches to lung metastasis management.
Research Focus
Key Achievements
Top Papers
- 1